Myeloid sarcoma (MS) is a rare manifestation of acute myeloid leukemia (AML)
characterized by extramedullary proliferation of myeloid blasts. Owing to the rarity of MS, the …

Aim Myeloid sarcoma (MS) is a rare tumour comprising myeloid blasts occurring at an
anatomical site other than the bone marrow. We sought to investigate both paediatric and …

Background Myeloid sarcoma (MS) is a rare, extramedullary tumor consisting of myeloid
blasts. Little is known about the genetic background of MS and the prognostic value of …

Myeloid sarcoma (MS) are extramedullary tumor masses consisting of a proliferation of
myeloid immature cells that efface the underlying tissue architecture.[1] It may develop de …

Myeloid sarcoma is a rare, architecture-effacing proliferation of myeloid blasts localized to
an extramedullary site, with or without concurrent bone marrow involvement. Clonal …

Myeloid sarcoma (MS) is a subgroup of acute myeloid leukemia (AML) where myeloid blasts
form a tumoral mass in extramedullary tissues [1]. MS may occur at any point during the …

Myeloid sarcoma (MS) is a distinct entity among myeloid neoplasms defined as a tumour
mass of myeloid blasts occurring at an anatomical site other than the bone marrow, in most …

Isolated myeloid sarcoma (MS) is a rare malignancy in which myeloid blast forms tumors at
various locations while the bone marrow (BM) remains cytomorphologically free from …

Abstract Context.-Myeloid sarcoma (MS) is a neoplasm of immature granulocytes,
monocytes, or both involving any extramedullary site. The correct diagnosis of MS is …

Myeloid sarcoma (MS) is a presentation of acute myeloid leukemia (AML) as a tumor mass
outside of the bone marrow. Viable cells from MS are frequently unavailable for cytogenetic …